For this reason, we used MDA-MB-231.hVCAM1.hCD1d tumor cells with median CD1d expression level, and used CD1d high expressing Hela.hCD1d cells to mimic DCs with high antigen presenting capacity. This evidence concerns the gene CD1D and neoplasm.